Patient Surveillance After Cancer Treatment

TRAMA

Patient Surveillance After Cancer Treatment covers the history of cancer patient surveillance after curative-intent treatment, the rationale, the methodologies used in the past and at present, the methodologies that will probably emerge in the future, the costs of surveillance, the definitions of various terms used in the field, and how those who are interested in the topic can get more information about it from the internet. The secondary focus of the book is to publicize the need for well-designed, adequately powered randomized clinical trials comparing two (or more) surveillance strategies for each type of cancer.The audience includes all oncologists, cancer researchers, medical economists and policy makers in government and insurance companies, and finally, interested patients.This book is part of the Current Clinical Oncology series, which provides cutting-edge knowledge of cancer diagnosis, management, and treatment. World renowned experts share their insights in all the major fields of clinical oncology. From the fundamentals of pathophysiology to the latest developments in experimental and novel therapies, Current Clinical Oncology is an indispensable resource for today’s practicing oncologist.

SOMMARIO

1. Overview David Y. Johnson and Frank E. Johnson 2. Introduction to Cancer Surveillance StrategiesBrooke Crawford and David D. Greenberg 3. Using Decision Analysis to Model Cancer SurveillanceKim E.M. van Kessel, Sandra M.E. Geurts, André L.M. Verbeek, and Ewout W. Steyerberg 4. Cancer Survivorship: Monitoring the Long-Term and Late Effects of Treatment Craig C. Earle and Jennifer Deevy 5. Upper Aerodigestive Tract Carcinoma David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson 6. Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint: Europe Béatrix Barry and Dominique De Raucourt 7. Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint: Japan Torahiko Nakashima, Ryuji Yasumatsu, and Shizuo Komune 8. Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint: Canada Richard W. Nason and James B. Butler 9. Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson 10. Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma Surveillance Counterpoint: Australia Leigh Delbridge 11. Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma Surveillance Counterpoint: Japan Ryuji Yasumatsu, Torahiko Nakashima, and Shizuo Komune 12. Lung Carcinoma Shilpi Wadhwa, David Y. Johnson, and Frank E. Johnson 13. Lung Carcinoma Surveillance Counterpoint: Australia Michael Boyer and Kate Mahon 14. Lung Carcinoma Surveillance Counterpoint: Japan Tokujiro Yano and Yoshihiko Maehara 15. Lung Carcinoma Surveillance Counterpoint: Canada Gail Darling, Yee Ung, Peter Ellis, Lorraine Martelli-Reid, and Bill Evans 16. Esophagus Carcinoma Shilpi Wadhwa, David Y. Johnson, and Frank E. Johnson 17. Esophagus Carcinoma Surveillance Counterpoint: Australia Bernard Mark Smithers, Janine M. Thomas, and Bryan H. Burmeister 18. Esophagus Carcinoma Surveillance Counterpoint: Japan Masaru Morita and Yoshihiko Maehara 19. Stomach Shilpi Wadhwa, David Y. Johnson, and Frank E. Johnson 20. Stomach Carcinoma Surveillance Counterpoint: USA Andrew Coleman and Douglas Tyler 21. Stomach Carcinoma Surveillance Counterpoint: Japan Yoshihiro Kakeji, Masaru Morita, and Yoshihiko Maehara 22. Pancreatic Adenocarcinoma David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson 23. Pancreatic Adenocarcinoma Surveillance Counterpoint: USA Tanios S. Bekaii-Saab 24. Pancreatic Adenocarcinoma Surveillance Counterpoint: Europe Richard A. Smith, Jane V. Butler, and John P. Neoptolemos 25. Pancreatic Adenocarcinoma Surveillance Counterpoint: Japan Ken Shirabe and Yoshihiko Maehara 26. Pancreatic Adenocarcinoma Surveillance Counterpoint: Canada Malcolm J. Moore and Anastasios Stathis 27. Liver and Biliary Tract Carcinoma David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson 28. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Europe Michele Colledan 29. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Australia Michael D. Crawford 30. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Japan Akinobu Taketomi and Yoshihiko Maehara 31. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Canada Oliver F. Bathe and Kelly Warren Burak 32. Colon and Rectum CarcinomaDavid Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson 33. Colon and Rectum Carcinoma Surveillance Counterpoint: USA Mohamedtaki A. Tejani and Steven J. Cohen 34. Colon and Rectum Carcinoma Surveillance Counterpoint: Australia Toufic El-Khoury, Michael Solomon, and Jane Young 35. Colon and Rectum Carcinoma Surveillance Counterpoint: Japan Yasushi Toh and Yoshihisa Sakaguchi 36. Colon and Rectum Carcinoma Surveillance Counterpoint: Canada Marko Simunovic 37. Anal Carcinoma David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson 38. Anal Carcinoma Surveillance Counterpoint: USA Jonathan M. Hernandez, Erin M. Siegel, Abby Koch, and David Shibata 39. Anal Carcinoma Surveillance Counterpoint: Australia Toufic El-Khoury, Michael Solomon, and Jane Young 40. Anal Carcinoma Surveillance Counterpoint: Japan Yoshihisa Sakaguchi and Yasushi Toh 41. Anal Carcinoma Surveillance Counterpoint: CanadaNatasha Press and John Hay 42. Soft Tissue Sarcoma David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson 43. Soft Tissue Sarcoma Surveillance Counterpoint: USA Valeriy Sedov and Janice M. Mehnert 44. Soft-Tissue Sarcoma Surveillance Counterpoint: Japan Shuichi Matsuda and Yukihide Iwamoto 45. Soft Tissue Sarcoma Surveillance Counterpoint: Canada Lloyd A. Mack and Vivien H.C. Bramwell 46. Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson 47. Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma Surveillance Counterpoint: Japan Shuichi Matsuda and Yukihide Iwamoto 48. Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma Surveillance Counterpoint: Canada Timothy R. Asmis, Joel Werier, and Shailendra Verma 49. Cutaneous Melanoma David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson 50. Cutaneous Melanoma Surveillance Counterpoint: USA Gerald Linette and Lynn A. Cornelius 51. Cutaneous Melanoma Surveillance Counterpoint: Australia Michael A. Henderson 52. Cutaneous Melanoma Surveillance Counterpoint: Japan Yoichi Moroi 53. Breast Carcinoma David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson 54. Breast Carcinoma Surveillance Counterpoint: USA Kelli Pettit and Julie A. Margenthaler 55. Breast Carcinoma Surveillance Counterpoint: Europe Stefano Ciatto 56. Breast Carcinoma Surveillance Counterpoint: Australia Andrew J. Spillane and Meagan E. Brennan 57. Breast Carcinoma Surveillance Counterpoint: Japan Eriko Tokunaga and Yoshihiko Maehara 58. Endometrial Carcinoma David Y. Johnson, Shilpi Wadhwa, and Frank E. Johnson 59. Endometrial Cancer Surveillance Counterpoint: USA Amit Bhate, Eric Donnelly, John Lurain, Julian Schink, and William Small Jr. 60. Endometrial Cancer Surveillance Counterpoint: USA Summer B. Dewdney and Premal H. Thaker<

AUTORE

Dr. Frank E. Johnson, MD

ALTRE INFORMAZIONI

• Condizione: Nuovo
• ISBN: 9781603279680
• Collana: Current Clinical Oncology
• Dimensioni: 279 x 210 mm Ø 15319 gr
• Formato: Copertina rigida
• Illustration Notes: XXI, 538 p.
• Pagine Arabe: 538
• Pagine Romane: xxi